IRVINE, Calif., July 25 /PRNewswire-FirstCall/ -- Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, plans to issue a press release announcing its financial results for the second quarter and six months ended June 30, 2007, before the market opens on Wednesday, August 1, 2007, and to host a conference call to be webcast live on the Company’s website (http://www.endocare.com/investors/webcasts.php) at 11:00 a.m. Eastern Time that same day.
Web participants are encouraged to go to the Company’s website (http://www.endocare.com/investors/webcasts.php) at least 15 minutes prior to the start of the call to register, download and install any necessary audio software. The online archived replay will be available immediately following the conference call at http://www.endocare.com/investors/webcasts.php.
About Endocare
Endocare, Inc. -- http://www.endocare.com -- is an innovative medical device company providing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).
Investor Contact: Media Contact: For Additional Information: Matt Clawson Len Hall Craig T. Davenport, CEO Allen & Caron, Inc. Allen & Caron, Inc. Michael R. Rodriguez, CFO (949) 474-4300 (949) 474-4300 Endocare, Inc. matt@allencaron.comlen@allencaron.com (949) 450-5400
Endocare, Inc.
CONTACT: investors, Matt Clawson, matt@allencaron.com, or media, Len Hall,len@allencaron.com, both of Allen & Caron, Inc. for Endocare, Inc.,+1-949-474-4300; or Craig T. Davenport, CEO, or Michael R. Rodriguez, CFO,both of Endocare, Inc., +1-949-450-5400
Web site: http://www.endocare.com/
